NCT01406977View on ClinicalTrials.gov

Dose Escalation Study to Evaluate the Safety and Tolerability of Multiple Infusions of BPS804 in Adults With Hypophosphatasia (HPP)

PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Hypophosphatasia
Interventions
DRUG

BPS804

Trial Locations (1)

97074

Mereo BioPharma 3 Ltd Investigative Site, Würzburg

Sponsors

Collaborators (2)

Mereo BioPharma
Novartis
All Listed Sponsors
collaborator

Mereo BioPharma

INDUSTRY

collaborator

Novartis

INDUSTRY

lead

Ultragenyx Pharmaceutical Inc

INDUSTRY